Articles in Scholarly Journals [Incomplete List]

1. In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line
   Cancer Immunology, Immunotherapy, vol. 55, no. 12, pp. 1480–1490, 2006
2. Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells
   Clinical Immunology, vol. 119, no. 2, pp. 135–145, 2006
3. Constitutively Active STAT5b Induces Cytokine-Independent Growth of the Acute Myeloid Leukemia???Derived MUTZ-3 Cell Line and Accelerates Its Differentiation Into Mature Dendritic Cells
   Journal of Immunotherapy, vol. 29, no. 2, pp. 188–200, 2006
4. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
   British Journal of Haematology, vol. 134, no. 3, pp. 283–293, 2006
5. Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma
   Clinical Cancer Research, vol. 11, no. 17, pp. 6400–6407, 2005
6. Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes
   Blood, vol. 106, no. 8, pp. 2663–2670, 2005
7. Interleukin-12 Increases Proliferation and Interferon-? Production but Not Cytolytic Activity of Human Antigen-Specific Effector Memory Cytotoxic T Lymphocytes: Power of the Effect Depends on the Functional Avidity of the T Cell and the Antigen Concentration
   Human Immunology, vol. 66, no. 11, pp. 1137–1145, 2005
8. A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7(11–20) cytotoxic T lymphocyte epitope
   Vaccine, vol. 23, no. 31, pp. 4005–4010, 2005
9. Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particles
   Gynecologic Oncology, vol. 96, no. 3, pp. 897–901, 2005
10. Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer
    Clinical Immunology, vol. 114, no. 2, pp. 119–129, 2005
11. Identification of a potential human telomerase reverse transcriptase–derived, HLA-A1–restricted cytotoxic T-lymphocyte epitope
    Cancer Immunology, Immunotherapy, vol. 54, no. 7, pp. 703–712, 2005
12. Human Telomerase Reverse Transcriptase-Transduced Human Cytotoxic T Cells Suppress the Growth of Human Melanoma in Immunodeficient Mice
    Cancer Research, vol. 64, no. 6, pp. 2153–2161, 2004
13. Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer
    Gastroenterology, vol. 123, no. 6, pp. 1877–1888, 2002
14. Differential Effects of Notch Ligands Delta-1 and Jagged-1 in Human Lymphoid Differentiation
    Journal of Experimental Medicine, vol. 194, no. 7, pp. 991–1002, 2001
15. Changing T cell specificity by retroviral T cell receptor display
    Proceedings of the National Academy of Sciences, vol. 97, no. 26, pp. 14578–14583, 2000
16. Transgenic Research, vol. 9, no. 2, pp. 155–159, 2000
17. Enrichment of an Antigen-Specific T Cell Response by Retrovirally Transduced Human Dendritic Cells
    Cellular Immunology, vol. 195, no. 1, pp. 10–17, 1999
18. Lysis of Syngeneic Tumor B Cells by Autoreactive Cytotoxic T Lymphocytes Specific for a CD 19 Antigen-Derived Synthetic Peptide
    Journal of Immunotherapy, vol. 19, no. 5, pp. 346–356, 1996
19. Integration vectors for antibody chimerization by homologous recombination in hybridoma cells
    European Journal of Immunology, vol. 25, no. 3, pp. 792–797, 1995